Hematologic Malignancy
Monoclonal B-Cell Lymphocytosis
CI-CAN-00006047MBLExplore in graph →
HematologicNon-malignant
Loading cancer entity…
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00006047MBLExplore in graph →
Clinical trials
10 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00923507 | Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL) | recruiting | — | 1,000 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Sep 28, 2026 | clinicaltrials |
| NCT06536452 | Hematopoiesis in MBL and CLL Versus Healthy Age-Matched Control Subjects | recruiting | — | 50 | Mayo ClinicOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT00626496 | Family Study of Lymphoproliferative Disorders | recruiting | — | 3,000 | Mayo ClinicOTHER | 1 | Oct 14, 2025 | clinicaltrials |
| NCT06416267 |
Data updated 2 days agoSource updated Sep 28, 2026source: clinicaltrials
| Risk and Clinical Consequences of Low Count Monoclonal B-cell Lymphocytosis (LC MBL)(MBL RiskConseq) |
| not yet recruiting |
| — |
| 1,500 |
| University of HaifaOTHER |
| 0 |
| May 16, 2024 |
| clinicaltrials |
| NCT05718986 | Familial B-cell Lymphoproliferative Disorders(Familial_LPD) | not yet recruiting | — | 1,000 | University of HaifaOTHER | 0 | May 8, 2024 | clinicaltrials |